Ratings by Piper Sandler
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Kelsey Goodwin | Day One Biopharmaceuticals | DAWN | Downgrade | Neutral (Overweight) |
N/A (N/A) |
12.78 (21.20) |
65.88% | Details |
| 3/6/2026 | Billy Fitzsimmons | Oracle | ORCL | Maintain | Overweight (N/A) |
240.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 24,618 more... | |||||||||
